NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target

Figure 2

NEIL3 was upregulated in lung cancer and was associated with worse clinical features. Notes: (a–d) a higher NEIL3 expression was found in LUAD, LUAD+GTEx, LUSC, and LUSC+GTEx cohorts; (e, f) clinical correlation of NEIL3 in TCGA-LUAD and TCGA-LUSC.

(a)

(b)

(c)

(d)

(e)

(f)